Campaigning & Advocacy

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Our campaigns

We run campaigns throughout the year, and need you to get involved and help raise awareness.

What is campaigning and advocacy?

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Know your rights toolkit

We have produced a number of bitesize pieces of information to help you understand the options that are available to you, access further information and make informed decisions.

Patient Advocacy Groups

We are involved with a number of organisations and coalitions on your behalf which, through collaborative working, aim to ensure that the collective voice of blood cancer patients is heard.

Working with the pharmaceutical industry

We work with the pharmaceutical industry to ensure that they take the interests of patients into account when developing new drugs and treatments for blood cancer patients.

Health Technology Appraisals

This involves working with bodies such as the National Institute of Clinical Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG) to ensure that the views of patients are taken into account when making decisions over access to drugs and treatments.

In memory giving

In memory giving is a way to remember your loved ones and enables you to leave a legacy that helps others living with leukaemia.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

May 20th

Five things you need to know about bruising right now

As the UK’s leading leukaemia charity, we’re here to help you learn a little bit more about bruises - and the types of bruising that you should be worried about. ...

May 10th

Ropeginterferon alpha 2b rejected and will not be available in Scotland

Charities including Leukaemia Care campaigned for the Scottish Medicines Consortium (SMC) to approve ropeginterferon alpha 2b (brand name of Besremi) on the NHS in Scotland for the treatment of polycthaemia vera (PV) patients. ...

May 10th

Is ‘telemedicine’ our new normal?

As the COVID-19 virus is likely to remain prevalent for the foreseeable future, and as the risks to clinically extremely vulnerable (CEV) patients remain, in this article we investigate the future of telephone consultations. Is ‘telemedicine’ our new normal? ...